News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Novartis Divests Product to Recordati, Plexus Ventures Facilitated Deal
Plexus Ventures Concludes Product Divestment Assignment Los Angeles, California — Plexus Ventures is pleased to announce the successful completion of its most recent divestment project. Plexus provided professional services to Novartis Consumer Health in the...
Plexus Ventures Launches Custom Business Development Services to Augment Clients’ Internal Expertise
In 2010, Plexus Ventures has achieved a significant milestone, 20 years in business. For the last two decades, Plexus Ventures has provided superior business development services and strategic advice to firms of all sizes in the Pharmaceutical, Biotech and Consumer...
Events
BIO International Convention - Boston
June 16 – 19, 2025
Click to Schedule a Meeting
CHPI - Frankfurt
October 28 – 30, 2025
Click to Schedule a Meeting
Articles
Nucleic acid delivery: Are you developing what Big Pharma seeks?
Apr 11, 2023
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.